NPM1 and acute myeloid leukemia: In conclusion, the data demonstrate the relevance of our deconvolution approach on bulk RNA-Seq to separate AML, especially those with mutated NPM1, with high and low monocyte percentages to predict the patient’s response to Venetoclax.